Biochemistry Research International

Translationally Controlled Tumor-Associated Protein


Publishing date
13 Jul 2012
Status
Published
Submission deadline
13 Jan 2012

Lead Editor

1Department of Surgery, The Methodist Hospital Research Institute, The Methodist Hospital System, Houston, TX, USA

2Cell Cycle Group, Institute of Genetics and Development of Rennes, Faculty of Medicine, University of Rennes 1, CNRS UMR 6061, Rennes, France


Translationally Controlled Tumor-Associated Protein

Description

Translationally Controlled Tumor-Associated Protein (TCTP) has been discovered in 1983 in mouse erythroleukemia cells. Over the years, it became evident that TCTP is an important player in a number of basic cell physiology events in cancer, embryo development, cell cycle, apoptosis, proliferation, growth, stress response, allergy, gene regulation, and heat-shock response. However, despite the nearly three decades of research, we only start to understand the role of TCTP in animal and plant embryo development through its participation in cell cycle, proliferation, and growth regulation, and the exact role(s) of TCTP in many complex cellular processes still remain(s) a mystery. One of the key questions in cancer research is the role of TCTP in tumor reversion, the rare event leading to tumor regression, and a “miraculous” cure; is TCTP involved in gene regulation or rather modification of the cytoskeleton of cancer cells during this process? We invite authors to submit original research and review papers that seek to understand the role of TCTP in cell physiology and pathology. We are interested in articles that explore various aspects of molecular, structural, and physiological role of TCTP in different cellular systems. Potential TCTP topics include, but are not limited to:

  • Structure and interaction with other proteins
  • Role in gene regulation
  • Involvement in cytoskeleton regulation
  • Function in cancer
  • Role in apoptosis
  • Role in cell growth, proliferation, and cell cycle
  • Translational and posttranslational regulation

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/bcri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 432590
  • - Editorial

Translationally Controlled Tumor-Associated Protein

Malgorzata Kloc | Jacek Z. Kubiak | Rafik Mark Ghobrial
  • Special Issue
  • - Volume 2012
  • - Article ID 204960
  • - Review Article

Biological Effects of Mammalian Translationally Controlled Tumor Protein (TCTP) on Cell Death, Proliferation, and Tumorigenesis

Michiyo Nagano-Ito | Shinichi Ichikawa
  • Special Issue
  • - Volume 2012
  • - Article ID 871728
  • - Research Article

Cytoplasmic and Nuclear Localization of TCTP in Normal and Cancer Cells

Yu-Ping Ma | Wu-Ling Zhu
  • Special Issue
  • - Volume 2012
  • - Article ID 541906
  • - Research Article

Association of TCTP with Centrosome and Microtubules

Mariusz K. Jaglarz | Franck Bazile | ... | Jacek Z. Kubiak
  • Special Issue
  • - Volume 2012
  • - Article ID 105203
  • - Review Article

TCTP in Development and Cancer

Magdalena J. Koziol | John B. Gurdon
  • Special Issue
  • - Volume 2012
  • - Article ID 369384
  • - Review Article

Role of Translationally Controlled Tumor Protein in Cancer Progression

Tim Hon Man Chan | Leilei Chen | Xin-Yuan Guan
  • Special Issue
  • - Volume 2012
  • - Article ID 831940
  • - Research Article

Sumoylation of Human Translationally Controlled Tumor Protein Is Important for Its Nuclear Transport

Gnanasekar Munirathinam | Kalyanasundaram Ramaswamy
Biochemistry Research International
 Journal metrics
Acceptance rate6%
Submission to final decision63 days
Acceptance to publication34 days
CiteScore1.670
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.